This single-center, open-label, first-in-human(FIH) pilot study was conducted at The First Affiliated Hospital of Guangzhou Medical University in China, in patients with suspected malignant solid tumors to explore the safety and efficacy of [64Cu]Cu-FAPI-XT117 PET/CT. Methods: This ...